D&C Biotechnology Inc. Signs Research Collaboration Agreement with Mongolia’s New Medical University
- 2024.03.03
D&C Biotechnology Inc. (CEO Sungsoo Park) announced that it signed a research collaboration agreement on March 1 with Mongolia’s New Medical University (Dean Ambaga Meogombo) to localize point-of-care testing (POCT) devices and conduct related joint research and field validation.
The agreement aims to establish a cooperative framework for the localization of POCT devices and digital healthcare in Mongolia. The two parties will jointly pursue research, business development, and academic activities while supporting the training and exchange of medical professionals.
Key areas of cooperation include:
- Joint research and development for the localization of POCT devices.
- Exchange and research on AI-based digital healthcare technologies.
- Support for research activities and employment opportunities through the exchange of facilities and personnel.
- Development and participation in educational programs linked to industry-academia collaboration.
Sungsoo Park, CEO of D&C Biotechnology Inc., stated, “Through close collaboration, we aim to achieve both the localization of POCT and in vitro diagnostic medical devices in Mongolia and the cultivation of talent. We hope this partnership will serve as a stepping stone to significantly improve and advance healthcare systems in developing countries worldwide, starting with Mongolia.”
© 2025 D&C Biotechnology Inc. All Rights Reserved.